# A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)

> **NCT04665570** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2000 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** BAY81-9783 (Acarbose/Metformin)

## Key facts

- **NCT ID:** NCT04665570
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-21
- **Primary completion:** 2023-09-09
- **Final completion:** 2024-09-05
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04665570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04665570, "A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04665570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*